Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin effects on emotional and reward-related brain processes in PTSD
NL-OMON20321Active, not recruiting
- Sponsor
- Academic Medical Center
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Academic Medical Center. Primary endpoints: Acute effects of intranasal oxytocin on emotional-related brain processes and Acute effects of intranasal oxytocin on reward-related brain processes. Started Jul 2012; status: active, not recruiting.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON20321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20321.